← Devices & Neurotechnology
Details checkedStatus confirmedCheckedcompany
MDHearing NEO XS OTC Hearing Aids
Also known as: NEO XS, MDHearing NEO XS, MDHearing NEO XS PRO
MDHearing
Company
MDHearing
Program Type
Device
Modality
Hearing Aid/Software
Stage
Marketed
Status
Marketed
Target Gene
—
Route / Mode
External in-ear OTC hearing aids plus optional telehealth support
Confidence
78%
Status Confidence
Status confirmed
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
United States
Population
adult, age-related, mild-moderate, post-lingual
Trial IDs
0
Mechanism
Budget direct-to-consumer OTC in-ear rechargeable hearing aids for adults with perceived mild to moderate hearing loss, with telehealth setup and support options.
Indications
Notes
Scouting-level budget OTC/DTC row. Included for market completeness, but kept Tier 3 because it is less strategically differentiating than regulated software, major-branded OTC, or premium prescription platforms.
Evidence & Sources
2 structured sourcesRelated Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed